Intranasal COVID-19 vaccine: Bharat Biotech enters licensing pact with Washington University School of Medicine for distribution

While the Phase I trials will take place in St. Louis University’s Vaccine amp; Treatment Evaluation Unit, Bharat Biotech, upon obtaining the required regulatory approval, will pursue further stages of clinical trials in India and undertake large scale manufacture of the vaccine at its GMP facility located in Genome Valley, Hyderabad.

from Moneycontrol Business News https://ift.tt/2RQFAuK